Show simple item record

dc.contributor.authorRiyat, MS
dc.date.accessioned2019-09-04T13:10:45Z
dc.date.available2019-09-04T13:10:45Z
dc.date.issued1995-04
dc.identifierhttp://hinari-gw.who.int/whalecomwww.ncbi.nlm.nih.gov/whalecom0/pubmed/7790139
dc.identifierhttp://hdl.handle.net/11295/31744
dc.identifier.citationInt J Dermatol. 1995 Apr;34(4):249-55en
dc.identifier.urihttps://library.adhl.africa/handle/123456789/7515
dc.description.abstractBACKGROUND: Childhood leukemia and lymphoma are common problems in Tropical Africa, including Kenya. Studies done in Western populations indicate that 25-50% of patients with leukemia and lymphoma have specific or nonspecific cutaneous signs. In dark-skinned patients, reports of such mucocutaneous manifestations are scarce. The lesions in these patients may easily be missed, if not specifically looked for. METHOD: Eighty-six indigenous Kenyan children with a confirmed diagnosis of leukemia or lymphoma were specifically examined for any mucocutaneous manifestations at presentation, during their treatment, and during subsequent follow-up. Whenever possible, an attempt was made to determine the causes of these lesions. All patients were given standard therapy for the primary hematologic disorder. RESULTS: Two-thirds of the patients had mucocutaneous symptomatology at presentation: 17.4% had skin infiltration by the malignant cells. During therapy an even larger number developed nonspecific skin manifestations. Most of these were the result of myelosuppression, immunosuppression, or direct cytotoxic effects on tissues. CONCLUSIONS: Mucocutaneous manifestations in black children with leukemia and lymphoma are very common.en
dc.language.isoenen
dc.publisherUniversity of Nairobien
dc.titleMucocutaneous manifestations of lymphomas and leukemias in black Kenyan children.en
dc.typeArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record